The Value of Folic Acid Combined with Low Molecular Weight Heparin in the Treatment of Recurrent Abortion
Abstract
Objective: To retrospectively analyze the effect of folic acid combined with low molecular weight heparin regimen on recurrent abortion in hospital. Methods:Â The inclusion period was from February 2022 to February 2023. During this period, patients with recurrent abortion in the hospital were studied and discussed, including 70 patients. They were randomly assigned to a control group (35 patients were treated with low molecular weight heparin calcium and aspirin) and an observation group (35 patients were treated with folic acid on the basis of the control group). Relevant data were collected and sorted out, and finally processed using statistics. Results: The data of treatment results were processed by the statistical system, and the results (P<0.05) showed that the observation group had better information on various data such as hormone indicators, pregnancy outcome, and immune function indicators after treatment. Conclusion:Â The application of folic acid combined with low molecular weight heparin regimen is conducive to the smooth development of the treatment of recurrent abortion, can help patients control hormone indicators within a reasonable range, improve immune function and pregnancy outcomes, and has important significance in improving treatment effectiveness.
References
[2] Cheng TT, Mao XW. The Efficacy of Folic Acid Combined with Low Molecular Weight Heparin in the Treatment of Recurrent Abortion and Its Effect on the Levels of Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor-1 in Patients with Recurrent Abortion [J]. China Maternal and Child Health Care, 2022, 37 (13): 2421-2424.
[3] Ke SC, Xu ZY. Effects of Low Molecular Weight Heparin Combined with Low Dose Aspirin on Coagulation Parameters and Th17/Treg Cytokines in Patients with Recurrent Abortion [J]. Chinese Journal of Family Planning, 2021,29 (3): 461-465.
[4] Lu XJ, Liang JM, Shen LL, et al Effects of Low Molecular Weight Heparin Combined with Low Dose Aspirin on Prethrombotic State, Liver Function, and Immune Function in Patients with Recurrent Abortion [J]. Electronic Journal of Developmental Medicine, 2021,9 (3): 214-219.
[5] Cai RB, He XT, Lin XH. The Effect of Low Molecular Weight Heparin Combined with Low Dose Aspirin in the Treatment of Recurrent Abortion and Its Impact on Coagulation Indicators [J]. Chinese Practical Medicine, 2020,15 (23): 128-130.
[6] Li ZN, Wu SF, Wang ML. The Effect of Low Molecular Weight Heparin on the Levels of Th1, Th17, and Related Chemokines in Patients with Unexplained Recurrent Abortion During Pregnancy [J]. Chinese Journal of Practical Medicine, 2022,49 (23): 30-34.
[7] Li JX. Clinical Evaluation of Low Molecular Weight Heparin Combined with Low Dose Aspirin in the Treatment of Autoimmune Recurrent Abortion [J]. Heilongjiang Medical Science, 2019, 42 (4): 157-158.
Copyright (c) 2023 Lingyan Zhang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
